Limiting treatment plan complexity by applying a novel commercial tool.

MLC aperture shape controller complexity metrics plan complexity plan quality metric treatment planning

Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 19 12 2019
revised: 20 04 2020
accepted: 22 04 2020
pubmed: 22 5 2020
medline: 22 6 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the aperture shape controller (ASC) tool recently introduced in Eclipse TPS (Varian Medical Systems, Palo Alto, CA). The performance of ASC was assessed in terms of the overall plan quality using a plan quality metric, the reduction in plan complexity through the analysis of 14 of the most common plan complexity metrics, and the change in plan deliverability through 3D dosimetric measurements. Similarly, plans optimized limiting the total number of delivered monitor units was assessed and compared. The two strategies were also combined to assess their potential combination. The plans optimized by exploiting the ASC generally show a reduced number of total Monitor Units, a more constant gantry rotation and a MLC modulation characterized by larger and less complicated shapes with leaves traveling shorter overall lengths. This first experience suggests that the ASC is an effective tool to reduce the unnecessary complexity of a plan. This turns into an increased plan deliverability with no loss of plan quality.

Identifiants

pubmed: 32436656
doi: 10.1002/acm2.12908
pmc: PMC7484888
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-34

Informations de copyright

© 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Références

Med Phys. 2009 Nov;36(11):5359-73
pubmed: 19994544
J Appl Clin Med Phys. 2017 Jan;18(1):186-195
pubmed: 28291941
Med Phys. 2008 Jan;35(1):310-7
pubmed: 18293586
Med Phys. 2013 Jul;40(7):071718
pubmed: 23822422
Med Phys. 2008 Jan;35(1):206-15
pubmed: 18293576
J Appl Clin Med Phys. 2013 May 06;14(3):4056
pubmed: 23652241
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):731-6
pubmed: 9112473
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8
pubmed: 12694826
Br J Radiol. 2011 Nov;84(1007):967-96
pubmed: 22011829
Phys Med Biol. 2018 Oct 16;63(20):20NT01
pubmed: 30238926
Br J Radiol. 2016;89(1057):20150445
pubmed: 26511276
Phys Med. 2019 Mar;59:79-85
pubmed: 30928069
Phys Med Biol. 2015 Mar 21;60(6):2587-601
pubmed: 25761616
Med Phys. 2018 Jun;45(6):2611-2619
pubmed: 29611213
Phys Med. 2017 Mar;35:73-80
pubmed: 28228330
Med Phys. 2010 Feb;37(2):505-15
pubmed: 20229859
Nat Rev Cancer. 2011 Jun;11(6):438-48
pubmed: 21593785
Rep Pract Oncol Radiother. 2018 Mar-Apr;23(2):121-125
pubmed: 29556140
Med Phys. 2011 Oct;38(10):5385-93
pubmed: 21992358
Med Phys. 2012 Nov;39(11):7160-70
pubmed: 23127107
Phys Med. 2014 May;30(3):296-300
pubmed: 24076257
Pract Radiat Oncol. 2012 Oct-Dec;2(4):296-305
pubmed: 24674168
Med Phys. 2014 Feb;41(2):021716
pubmed: 24506607
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):1-7
pubmed: 16618572
Rep Pract Oncol Radiother. 2019 Mar-Apr;24(2):227-232
pubmed: 30858766
Phys Med. 2018 Sep;53:86-93
pubmed: 30241759
Phys Med Biol. 2011 Mar 21;56(6):1853-63
pubmed: 21364259
J Appl Clin Med Phys. 2013 May 06;14(3):4114
pubmed: 23652245
Phys Med. 2019 Aug;64:98-108
pubmed: 31515041
Phys Med Biol. 2014 Dec 7;59(23):7315-40
pubmed: 25383976

Auteurs

Alessandro Scaggion (A)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Marco Fusella (M)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Giancarmelo Agnello (G)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Andrea Bettinelli (A)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Nicola Pivato (N)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Antonella Roggio (A)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Marco A Rossato (MA)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Matteo Sepulcri (M)

Radiation Oncology Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Marta Paiusco (M)

Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH